IMCR Immunocore Holdings plc

Nasdaq immunocore.com


$ 34.37 $ 2.67 (8.42 %)    

Wednesday, 15-Oct-2025 15:59:55 EDT
QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ 34.39
$ 31.80
$ 33.00 x 1
$ 38.00 x 300
$ 31.80 - $ 34.51
$ 23.15 - $ 39.33
370,022
na
1.73B
$ 0.69
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 02-26-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 guggenheim-assumes-immunocore-holdings-at-neutral

Guggenheim analyst Paul Jeng assumes Immunocore Holdings (NASDAQ:IMCR) with a Neutral rating.

 immunocore-hldgs-q2-eps-020-beats-023-estimate-sales-97964m-beat-94428m-estimate

Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0....

Core News & Articles

https://www.bloomberg.com/news/articles/2025-08-04/south-africa-gates-step-in-after-us-defunds-hiv-research

 hc-wainwright--co-reiterates-buy-on-immunocore-holdings-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 ...

 oppenheimer-maintains-outperform-on-immunocore-holdings-raises-price-target-to-86

Oppenheimer analyst Jeff Jones maintains Immunocore Holdings (NASDAQ:IMCR) with a Outperform and raises the price target fro...

 immunocore-hldgs-q1-gaap-eps-010-beats-039-estimate-sales-9388m-beat-8852m-estimate

Immunocore Hldgs (NASDAQ:IMCR) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0....

 jp-morgan-maintains-overweight-on-immunocore-holdings-lowers-price-target-to-50

JP Morgan analyst Jessica Fye maintains Immunocore Holdings (NASDAQ:IMCR) with a Overweight and lowers the price target from...

 needham-reiterates-buy-on-immunocore-holdings-maintains-71-price-target

Needham analyst Gil Blum reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $71 price target.

 mizuho-maintains-neutral-on-immunocore-holdings-lowers-price-target-to-33

Mizuho analyst Graig Suvannavejh maintains Immunocore Holdings (NASDAQ:IMCR) with a Neutral and lowers the price target from...

 hc-wainwright--co-reiterates-buy-on-immunocore-holdings-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 ...

 needham-reiterates-buy-on-immunocore-holdings-maintains-71-price-target

Needham analyst Gil Blum reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $71 price target.

 morgan-stanley-assumes-immunocore-holdings-at-equal-weight-maintains-price-target-of-35

Morgan Stanley analyst Andrew Galler assumes Immunocore Holdings (NASDAQ:IMCR) with a Equal-Weight rating and maintains Pric...

 hc-wainwright--co-reiterates-buy-on-immunocore-holdings-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 ...

 hc-wainwright--co-reiterates-buy-on-immunocore-holdings-maintains-100-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 ...

 needham-reiterates-buy-on-immunocore-hldgs-maintains-71-price-target

Needham analyst Gil Blum reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $71 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION